This investment will accelerate the company’s national market expansion to meet increasing demand for its real-time, risk adjusted clinical performance analytics tools. The company’s analytics are designed for healthcare providers and payers to improve quality, safety and cost-effectiveness in surgical and specialty care.
Last summer the company’s earlier round of Series B financing was led by RPM Ventures alongside existing investor Arboretum Ventures. Wolverine Venture Fund participated in earlier investment.
More Articles on Surgery Centers:
Roanoke Valley Center for Sight Seeks Approval for 3rd OR
Southern Surgery Center Earns Fourth AAAHC Accreditation
SourceMedical Partners With LaClaro
